| Adult Liver Carcinoma studied in …STUDIED_INderived67 of 67show fewer |
|---|
| → studied in | NCT02088775NA · completed PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01015833Phase 3 · completed Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02379377Phase 1 · active not recruiting 18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant · condition mapped ONTOLOGY_EXACT · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01899261NA · completed Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03211416Phase 1/Phase 2 · completed Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01730937Phase 3 · completed Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03267524NA · completed Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family Caregivers · condition mapped ONTOLOGY_EXACT · 67 trials mapped (1 active) | — | — | Adult Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02234986Phase 2 · completed A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04602026NA · completed The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric Cancer · condition mapped ONTOLOGY_EXACT · 67 trials mapped (1 active) | — | — | Adult Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04022746NA · completed An Investigational Scan (Magnetic Resonance Elastography) in Detecting Treatment Response in Patients With Advanced Liver Cancer · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04497038Phase 1/Phase 2 · terminated Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line Therapy · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02695628Phase 2 · completed [18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer · condition mapped ONTOLOGY_EXACT · 67 trials mapped (1 active) | — | — | Adult Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01624285Phase 2 · completed Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02683200early Phase 1 · completed MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer · condition mapped ONTOLOGY_EXACT · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02072356early Phase 1 · completed Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02024087Phase 1/Phase 2 · completed Study of Dalantercept and Sorafenib in Patients With Advanced Hepatocellular Carcinoma · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01896778NA · completed Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer · condition mapped ONTOLOGY_EXACT · 67 trials mapped (1 active) | — | — | Adult Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02072486NA · completed Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01900002Phase 2 · completed Sorafenib Tosylate and Yttrium Y 90 Glass Microspheres in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02964260NA · unknown RCT of TAE Simultaneously Combined Thermal Ablation for Large Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02337465NA · completed KV-CBCT and Ultrasound Imaging in Guiding Radiation Therapy in Patients With Prostate, Liver, or Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 67 trials mapped (1 active) | — | — | Adult Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01666756Phase 1 · completed Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01835223Phase 1/Phase 2 · completed Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04576572completed Comparison of Criteria for Liver Transplantation in Hepatocellular Carcinoma · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02409524Phase 2 · completed An Individualized Anti-Cancer Vaccine in Advanced Hepatocellular Carcinoma Subjects · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01010126Phase 2 · completed Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01395030Phase 2 · completed PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02057874NA · terminated 3-Tesla MRI Response to TACE in HCC (Liver Cancer) · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101036Phase 2 · completed Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00459108Phase 2 · terminated Dasatinib in Treating Patients With Advanced Liver Cancer That Cannot Be Removed by Surgery · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01829035Phase 3 · completed A Randomized, Controlled Phase III Trial of Sorafenib With or Without cTACE in Patients With Advanced HCC · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00321594Phase 1/Phase 2 · completed Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02042443Phase 2 · completed Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00787787Phase 2 · terminated Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver Cancer · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01405573Phase 3 · terminated Sorafenib in First-line Treatment of Advanced B Child Hepatocellular Carcinoma · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01839604Phase 1 · completed A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02447679Phase 2 · completed Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence · condition mapped ONTOLOGY_EXACT · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00427973Phase 2 · terminated AZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver Cancer · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01777594Phase 2 · completed Study of G-202 (Mipsagargin) as Second-Line Therapy Following Sorafenib in Hepatocellular Carcinoma · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01425879Phase 2 · completed MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01008566Phase 1 · completed Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01488487Phase 2 · completed Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00055692Phase 2 · completed Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02578602Phase 1 · completed MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01239355Phase 2 · terminated MK2206 in Treating Patients With Advanced Liver Cancer That Did Not Respond to Previous Therapy · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00365391Phase 2 · completed Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00608361Phase 1 · completed Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Liver Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00107536Phase 2 · completed Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02418988Phase 2 · unknown Trans-catheter Chemo-embolization Combined With rAd-p53 Gene Injection in Treatment of Advanced Hepatocellular Carcinoma · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006016Phase 2 · completed Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by Surgery · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00844168Phase 1 · completed Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver Transplant · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02070419Phase 2 · withdrawn TACE With or Without Radiation Therapy in Treating Patients With Stage A-C Liver Cancer · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00083226Phase 2 · completed Doxorubicin and Bortezomib in Treating Patients With Liver Cancer · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00604721Phase 2 · completed Selumetinib in Treating Patients With Locally Advanced or Metastatic Liver Cancer · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00639509Phase 2 · completed IMC-A12 in Treating Patients With Advanced Liver Cancer · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00023946Phase 2 · terminated BMS-247550 in Treating Patients With Liver or Gallbladder Cancer · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052364Phase 2 · completed Oxaliplatin in Treating Patients With Liver Cancer · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00238394Phase 2 · completed Cediranib Maleate in Treating Patients With Locally Advanced or Metastatic Liver Cancer · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00033462Phase 2 · completed Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00077441Phase 2 · completed Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer) · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01336452NA · unknown Noninvasive Surrogate Marker for Advanced Hepatocellular Carcinoma Response to Concurrent Chemoradiotherapy: MR Perfusion, Contrast Enhanced Ultrasound and Biomarkers · condition mapped CURATED_BROADER · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00071994Phase 2 · completed Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer) · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00028496Phase 1 · completed Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047333Phase 2 · terminated Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047346Phase 1 · completed Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030498Phase 1 · completed Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01194206Phase 2 · withdrawn Stereotactic Body Radiation Therapy in Liver Cancer That Cannot be Removed by Surgery or Transplant · condition mapped ALIAS · 67 trials mapped (1 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |